GPCR · Structure Therapeutics Inc ADR
United States · RS rating 5 · As of 2026-10-14
| Price | 21.88 USD |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 3 / 5 / 23 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 4 / 51 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +142.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +76.7% |
| Market cap (USD) | $3.3B |